ARTICLE | Company News

Napo, AsiaPharm Group Ltd. deal

June 20, 2005 7:00 AM UTC

Napo granted AsiaPharm exclusive Chinese development and commercialization rights to crofelemer to treat AIDS-related diarrhea, acute infectious diarrhea and pediatric diarrhea. AsiaPharm will contribute process development, manufacturing and pediatric formulation capabilities. Napo received an equity investment and is eligible for royalties. ...